Olaparib Oral Tablet [Lynparza] clinical trials

A Platform Study of Novel Agents in Combination With Radiotherapy in NSCLC

This study looks at combining radiotherapy with new drugs to treat non-small cell lung cancer that hasn't spread widely. Researchers want to find the safest and most effective dose of these new drugs, which help radiotherapy work better by making it harder for cancer cells to repair themselves.